author-photo

John B. Hogan

Bristol-Myers Squibb

13

Papers

331

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia

2017 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (9)
Heterocyclic modification of a novel bicyclo[3.1.0]hexane NPY1 receptor antagonist.

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (2)
Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists.

2012 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (2)
Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity.

2009 Behavioural Pharmacology
Show All
- Source
- Cite
- Save
Citations (56)
Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y1 receptor antagonist

2008 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (30)
Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping

2006 Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (54)
Soluble Aβ and cognitive function in aged F-344 rats and Tg2576 mice

2006 Behavioural Brain Research
Show All
- Source
- Cite
- Save
Citations (18)
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists

2006 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (22)
Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.

2006 Experimental and Clinical Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (15)